Mirth Connect Development & Integration Services

Mirth Connect powers one-third of all public Health Information Exchanges in the US, with deployments in 40+ countries. As the integration engine of choice for healthcare organizations at every maturity level, it handles HL7v2, FHIR, CDA, X12, DICOM, and custom format transformations — routing, filtering, and delivering clinical data between systems with precision and reliability. Taction provides end-to-end Mirth Connect services: from channel development and performance optimization to legacy migration, licensing guidance, and 24/7 managed support.

Calculate My Project Cost Connect With Experts

Let’s Discuss Your Technical Roadmap

Share a few details about your ecosystem, and we’ll prepare a preliminary integration strategy for our first call.

Mirth Connect Services We Provide

Channel development

Custom Mirth Connect channel configuration for HL7v2, FHIR, CDA, X12, DICOM, and custom format transformations. We build channels that route, filter, transform, and deliver healthcare data between your clinical systems.

Connect with expert now

Explore how we’ve helped hospitals, clinics, and healthcare startups

Integration Use Cases

ADT/demographics feeds between EHR and ancillary systems. Lab order/result interfaces (ORM/ORU). Scheduling interfaces (SIU). Clinical document routing (CDA/C-CDA). FHIR API gateway and transformation. Claims and eligibility (X12 837/835/270/271). Public health reporting (immunization registries, syndromic surveillance). HIE connectivity. EHR integration with Epic, Oracle Health, Allscripts, and athenahealth.

Tailored Services, Personalized Results

The 2025/2026 Licensing Change: What You Need to Know

Mirth Connect version 4.6+ requires a commercial license from NextGen Healthcare. The open-source community edition will no longer receive updates. Organizations have three options:

Case Study: HL7 to FHIR Migration

A health system needed to migrate from legacy HL7v2 to FHIR to meet ONC compliance deadlines. Taction designed and implemented a phased migration using Mirth Connect channels for bidirectional HL7v2-to-FHIR transformation. Results: 60% faster data exchange, full ONC interoperability compliance, zero downtime during migration, and 200+ channels migrated over 6 months.

Technology Stack

MiMirth Connect

TaTalend, Snowflake

DaDatawarehouse, Datalake

HLHL7 v2, HL7 v3

FHFHIR

Java

React Native

Flutter

APAPI

Turn your vision into reality. Contact us for a free quote.

Let's Schedule

Rapid Development : Experience the TURBO

✔ Agile & User-Centric – Accelerated MVP development for faster market entry.
✔ Shortest Time-to-Market – Our TURBO framework ensures speed & efficiency.

Awards & Recognitions

taction-clutch-top-wellness-app-developer

taction-clutch-top-app-development-company

taction-clutch-top-global-software-development-company

taction-clutch-top-artificial-intelligence-company

Let's Collaborate. We're Just a Click Away.

Frequently Asked Questions

As of version 4.6, no. New releases require a commercial license from NextGen Healthcare. Earlier open-source versions remain available but will not receive updates or security patches.

Yes. We migrate from Rhapsody, InterSystems HealthShare, Cloverleaf, and custom integration platforms to Mirth Connect.

A single channel (one-direction interface) costs $5,000–$15,000. Complex multi-channel implementations cost $50,000–$200,000+. Ongoing managed services start at $3,000–$8,000/month.

An MVP with mood tracking, journaling, and basic assessments can launch in 10–14 weeks. A full-featured platform with teletherapy, provider dashboard, and EHR integration typically takes 5–8 months.

Yes. We integrate with Epic, Oracle Health, Allscripts, athenahealth, and other EHR platforms via FHIR R4 APIs and HL7v2 interfaces so clinical data flows seamlessly between the app and your existing systems.

It depends on the claims your app makes. Apps that deliver structured therapeutic interventions (such as CBT or DBT programs) and make clinical outcome claims may qualify as digital therapeutics and require FDA review. We assess the regulatory pathway during the discovery phase before any development begins.